Table 1.
Pro- & anti-inflammatory factors (mean ± SD) | PI (n=86) |
Groups
|
HG (n=84)
|
---|---|---|---|
PC (n=90) | |||
CRP(mg/mL) | |||
At baseline | 8.4±3.9 | 7.9±3.3 | 1.7±1.6 a |
After intervention | 6.2±3.1 | 8.1±3.7 a | 1.9±1.7 a |
P values | p < 0.01 | p < 0.05 | P<0.05 |
IL-1 β(pg/mL) | |||
At baseline | 75±4.3 | 72± 3.8 | ND |
After intervention | 51±2.6 | 75±2.6 b | ND |
P values | p < 0.01 | p < 0.05 | ---- |
TNF- α(pg/mL) | |||
At baseline | 315±9.2 | 322±9.3 | ND |
After intervention | 225±4.7 | 318±4.9 a | ND |
P values | p < 0.001 | p < 0.05 | ---- |
IL-6(pg/mL) | |||
At baseline | 51±2.3 | 48±2.1 | ND |
After intervention | 68±2.6 | 50±3.1 b | ND |
P values | p < 0.01 | p < 0.05 | ---- |
IL-10(pg/mL) | |||
At baseline | 43±1.8 | 38±1.7 | 20±0.7 b |
After intervention | 70±4.8 | 35±1.8 a | 21±1.1 a |
P values | p < 0.001 | p < 0.05 | P<0.05 |